Paramagnetic and Superparamagnetic Inorganic Nanoparticles for T1-Weighted Magnetic Resonance Imaging
- 30 August 2018
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 25 (25), 2970-2986
- https://doi.org/10.2174/0929867324666170314124616
Abstract
Magnetic resonance imaging (MRI) has become a promising technique in the early diagnosis of cancers, especially the application of contrast agents can further enhance the detection limitation. Compared with the dark signal in “negative” contrast agents (T2), “positive” contrast agents (T1) with bright signal are more desirable for high-resolution imaging. However, the clinical used gadolinium complexes have short circulation time and the risk of nephrogenic system fibrosis. Therefore, to overcome the disadvantage of T2 agents and traditional T1 agents, it is very interesting to develop nano-scaled T1-weighted MRI contrast agents with safer and more precise imaging performance. The present review systematically summarized the recent progress of paramagnetic and superparamagnetic inorganic nanoparticles as T1-weighted MRI contrast agents, including gadolinium oxide nanoparticles, gadolinium-based upconversion nanoparticles, manganese oxide nanoparticles, and ultra-small iron oxide nanoparticles. Moreover, we also described their applications in multi-modal imaging and visualized theranostics.Keywords
This publication has 97 references indexed in Scilit:
- Magnetic/Upconversion Fluorescent NaGdF4:Yb,Er Nanoparticle-Based Dual-Modal Molecular Probes for Imaging Tiny Tumors in VivoACS Nano, 2013
- Engineered Iron-Oxide-Based Nanoparticles as Enhanced T1 Contrast Agents for Efficient Tumor ImagingACS Nano, 2013
- A Synergistically Enhanced T1–T2 Dual‐Modal Contrast AgentAdvanced Materials, 2012
- Paramagnetic nanoparticle T1 and T2 MRI contrast agentsPhysical Chemistry Chemical Physics, 2012
- Gadolinium-Encapsulating Iron Oxide Nanoprobe as Activatable NMR/MRI Contrast AgentACS Nano, 2012
- Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imagingBiomaterials, 2012
- Mesoporous Silica-Coated Hollow Manganese Oxide Nanoparticles as Positive T1 Contrast Agents for Labeling and MRI Tracking of Adipose-Derived Mesenchymal Stem CellsJournal of the American Chemical Society, 2011
- HSA coated MnO nanoparticles with prominent MRI contrast for tumor imagingChemical Communications, 2010
- Self-Confirming “AND” Logic Nanoparticles for Fault-Free MRIJournal of the American Chemical Society, 2010
- Au@MnO Nanoflowers: Hybrid Nanocomposites for Selective Dual Functionalization and ImagingAngewandte Chemie-International Edition, 2010